ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,297.10
-0.21%
Dow Jones
39,869.38
-0.10%
US Dollar vs MXN
16.7075
0.16%
Brent Oil
83.455
0.30%
Bitcoin
65,672.79
0.66%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Curagen Corp. (MM) (CRGN)

  7. Curagen Corp. (MM) (CRGN) Noticias

CRGN

Curagen Corp. (MM) (CRGN)

Curagen Corp. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CRGN
FechaHoraFuenteTítuloSímboloCompañía
02/10/200905:02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
01/10/200915:28Edgar (US Regulatory)(25-NSE)NASDAQ:CRGNCuragen Corp. (MM)
01/10/200913:29Business WireCelldex Therapeutics Announces Completed Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
30/09/200917:00Business WireCelldex and CuraGen Stockholders Approve Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
25/09/200915:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRGNCuragen Corp. (MM)
03/09/200905:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
28/08/200916:27Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:CRGNCuragen Corp. (MM)
17/08/200915:50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:CRGNCuragen Corp. (MM)
05/08/200913:03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CRGNCuragen Corp. (MM)
31/07/200905:00PR Newswire (US)CuraGen Reports Second Quarter 2009 Financial ResultsNASDAQ:CRGN
22/06/200916:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CRGNCuragen Corp. (MM)
19/06/200912:45Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CRGNCuragen Corp. (MM)
17/06/200905:30PR Newswire (US)CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast CancerNASDAQ:CRGNCuragen Corp. (MM)
10/06/200916:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CRGNCuragen Corp. (MM)
09/06/200914:22Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:CRGNCuragen Corp. (MM)
03/06/200914:42Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:CRGNCuragen Corp. (MM)
02/06/200905:30PR Newswire (US)CuraGen Updates CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
29/05/200915:50Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200905:54Business WireCelldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
28/05/200905:30PR Newswire (US)CuraGen to Present CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
19/05/200914:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CRGNCuragen Corp. (MM)
23/04/200910:03PR Newswire (US)/C O R R E C T I O N -- CuraGen Corporation/NASDAQ:CRGNCuragen Corp. (MM)
23/04/200905:30PR Newswire (US)CuraGen Reports First Quarter 2009 Financial ResultsNASDAQ:CRGNCuragen Corp. (MM)
10/03/200916:06Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CRGNCuragen Corp. (MM)
27/02/200905:30PR Newswire (US)CuraGen Announces Board of Director ChangesNASDAQ:CRGNCuragen Corp. (MM)
18/02/200905:30PR Newswire (US)CuraGen's Board of Directors to Evaluate Strategic InitiativesNASDAQ:CRGNCuragen Corp. (MM)
29/01/200905:30PR Newswire (US)CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009NASDAQ:CRGNCuragen Corp. (MM)
15/01/200912:33Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:CRGNCuragen Corp. (MM)
05/11/200805:30PR Newswire (US)CuraGen to Present at the Rodman & Renshaw Annual Global Investment ConferenceNASDAQ:CRGNCuragen Corp. (MM)
03/11/200805:45PR Newswire (US)CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with MetastNASDAQ:CRGNCuragen Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:CRGN

Su Consulta Reciente

USOTC
VNLEF
Vanoil Energy (CE)
USOTC
MCIM
Macau Capital (CE)
ASX
QFYDF
Quantify Technology
LSE
IG96
Citi Fun 25
BIT
F37350
Vontobel Financial Produ...
USOTC
CHLLF
China Literature (PK)
LSE
ZT60
Citi Fun 24
USOTC
ALLXF
Aris Gold (QX)
NASDAQ
AAYHNXX
Barclays Bank Plc Issuer...
NYSE
HPI
John Hancock Preferred I...
LSE
AV53
Citi Fun 27
LSE
0JBY
Elanders Ab
LSE
LEND
Sancus Lending
LSE
AMRQ
Amaroq Minerals
NYSE
HTH
Hilltop
ASX
CWX
Carawine Resources
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados